Relationship Between Endometriosis, Endometrioid Adenocarcinoma, Gliomatosis Peritonei, and Carcinoid Tumor in a Patient With Recurrent Ovarian Teratoma

review OA: closed CC0 ⤵ 2 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

This case report describes an unusual patient with recurrent ovarian teratoma, gliomatosis peritonei, endometriosis with malignant transformation, carcinoid tumor, and primary endometrial adenocarcinoma, suggesting peritoneal stem cells may undergo a wider spectrum of aberrant differentiation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-21 · read from full text

This case report describes a patient with recurrent mature ovarian teratoma who was found to have gliomatosis peritonei, endometriosis with malignant transformation into endometrial adenocarcinoma, and a carcinoid tumor during hysterectomy. The authors propose that the coexistence of these diverse tissue types suggests aberrant differentiation of totipotential subcoelomic or submesothelial stem cells in the peritoneum. This unusual combination highlights the potential for peritoneal stem cells to exhibit a wider spectrum of differentiation than previously recognized. Relevance to endometriosis: this paper is centrally about endometriosis, specifically detailing its malignant transformation into adenocarcinoma and its colocalization with other rare peritoneal tumors in a complex clinical presentation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Gliomatosis peritonei (GP) describes the implantation of mature neuroglial tissue in the peritoneum and is usually associated with mature ovarian teratoma but is also found in cases of immature teratoma. We report the case of a patient with recurrent mature ovarian teratoma, GP, endometriosis (with malignant transformation), and carcinoid tumor, found at the time of hysterectomy for a primary endometrial adenocarcinoma. This unusual combination of tumor types has not been reported earlier. Metaplasia of the totipotential subcoelomic or submesothelial stem cells is a recognized pathway for the development of endometriosis. Evidence from molecular genetic studies suggests that a similar process of stem cell differentiation may explain at least some cases of GP. The coexistence (and colocalization) of endometriosis, GP, and carcinoid tumor in this case raises the possibility that peritoneal stem cells may occasionally show an even wider spectrum of aberrant differentiation. This has relevance for the assessment and management of patients with synchronous gynecologic tumors or presumed metastatic disease.
Full text 1,389 characters · extracted from oa-doi-fallback · click to expand
Relationship Between Endometriosis, Endometrioid Adenocarcinoma, Gliomatosis Peritonei, and Carcinoid Tumor in a Patient With Recurrent Ovarian Teratoma - Mary Alexander - Nichola Cope - John Renninson - Ann Hong - Roderick H.W. Simpson - Raji Ganesan - Lynn Hirschowitz Gliomatosis peritonei (GP) describes the implantation of mature neuroglial tissue in the peritoneum and is usually associated with mature ovarian teratoma but is also found in cases of immature teratoma. We report the case of a patient with recurrent mature ovarian teratoma, GP, endometriosis (with malignant transformation), and carcinoid tumor, found at the time of hysterectomy for a primary endometrial adenocarcinoma. This unusual combination of tumor types has not been reported earlier. Metaplasia of the totipotential subcoelomic or submesothelial stem cells is a recognized pathway for the development of endometriosis. Evidence from molecular genetic studies suggests that a similar process of stem cell differentiation may explain at least some cases of GP. The coexistence (and colocalization) of endometriosis, GP, and carcinoid tumor in this case raises the possibility that peritoneal stem cells may occasionally show an even wider spectrum of aberrant differentiation. This has relevance for the assessment and management of patients with synchronous gynecologic tumors or presumed metastatic disease.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Carcinoid Tumor Carcinoma, Endometrioid Endometriosis Neoplasms, Multiple Primary Ovarian Neoplasms Uterine Neoplasms Carcinoid Tumor Carcinoid Tumor Carcinoma, Endometrioid Carcinoma, Endometrioid Diabetes Mellitus Endometriosis Endometriosis Female Humans Hyperthyroidism Hyperthyroidism Middle Aged Neoplasms, Multiple Primary Neoplasms, Second Primary

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

europepmc
last seen: 2026-09-04T06:17:57.233406+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:48.482574+00:00
unpaywall
last seen: 2026-09-04T06:34:25.427880+00:00
License: CC0 · commercial use OK